已收盤 09-19 16:00:00 美东时间
+0.075
+3.51%
Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its blockbuster therapy Keytruda to allow its use as a first-line combination thera...
09-18 19:08
Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC after Progression on
09-10 19:44
8月31日,万春医药(BYSI)盘中下跌2.05%,截至01:51,报1.91美元/股,成交2.59万美元。 财务数据显示,截至2024年06月30日,万春医药...
08-31 01:51
Beyondspring (BYSI) has released an update. BeyondSpring Inc., a foreign privat...
08-30 04:58
转自:氨基观察 作者 | 黄恺 分子胶被视为不可成药靶点的救赎,也成了万春医药的新希望。 今年3月份,万春医药的股价“起死回生”,月涨幅超过168%。核心原因在...
08-23 19:49
21世纪经济报道记者 韩利明 上海报道 同一天内,神经退行性疾病迎来两笔巨额交易,阿尔茨海默病(AD)领域的研发热潮或再被“引爆”。...
08-08 20:31
Beyondspring-After Series a-3 Financing 1St Close, Co, Seed Technology Limited ...
08-06 20:30
BeyondSpring (NASDAQ:BYSI) on Wednesday filed a prospectus related to a proposed offering of up to 10 million ordinary shares. This prospectus is not an offer to sell these securities. SEC Filing More...
06-13 05:32
Beyondspring (BYSI) has released an update. BeyondSpring Inc., a biopharmaceuti...
06-13 04:59
2023 年 12 月10日,FDA批准的基因编辑和基因治疗镰状细胞病疗法上市两天后,诺华的生物化学家 Pamela Ting 在美国血液学会年会上做了一份全体...
05-29 08:00